{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:13:03Z","timestamp":1755216783626,"version":"3.43.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Low\u2013molecular-weight heparin is cleared through the kidneys and is commonly used for anticoagulation in the pediatric population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Observation:<\/jats:title>\n            <jats:p>We present 3 challenging cases of children requiring anticoagulation in the context of acute kidney injury, nephrotic syndrome, and hemodialysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>A significant change in anti-factor Xa (anti-Xa) levels\u2014used for drug monitoring\u2014should prompt an assessment of renal function. In nephrotic syndrome, anti-Xa levels should be closely monitored when there is a change in the status of nephrotic disease activity. In hemodialysis patients, enoxaparin at once daily reduced dosing should be considered with trough and peak anti-Xa levels monitoring.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002045","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T02:11:46Z","timestamp":1608862306000},"page":"e1040-e1044","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Management of Anticoagulation Therapy in Patients With Thromboembolism in the Context of Renal Dysfunction: Challenging Cases and Practical Algorithms"],"prefix":"10.1097","volume":"43","author":[{"given":"Aban","family":"Bahabri","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology-Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony K.C.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology-Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Belostosky","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Nephrology, McMaster University, McMaster Children\u2019s Hospital, Hamilton, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir D.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology-Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2165\/00003088-200342120-00003","article-title":"Pharmacodynamic and pharmacokinetic properties of enoxaparin: Implications for clinical practice","volume":"42","author":"Fareed","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"suppl 1","key":"R2-20250804","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2000-9497","article-title":"Comparative pharmacokinetics of LMWHs","volume":"26","author":"Samama","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"R4-20250804","first-page":"31","article-title":"Low-molecular-weight heparin in pediatric patients","volume":"30","author":"Sutor","year":"2004","journal-title":"Semin Thromb Hemost"},{"issue":"suppl 2","key":"R5-20250804","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-144-9-200605020-00011","article-title":"Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency","volume":"144","author":"Lim","year":"2006","journal-title":"Ann Intern Med"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9343(78)90848-3","article-title":"Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome","volume":"65","author":"Kauffmann","year":"1978","journal-title":"Am J Med"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jtcvs.2008.09.031","article-title":"Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion","volume":"137","author":"Odegard","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1161\/01.cir.0000436140.77832.7a","article-title":"Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association","volume":"128","author":"Giglia","year":"2013","journal-title":"Circulation"},{"key":"R10-20250804","first-page":"245","article-title":"Dosing of Enoxaparin in Renal Impairment","volume":"42","author":"Shaikh","year":"2017","journal-title":"P T"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0049-3848(91)90141-I","article-title":"Delayed elimination of enoxaparin in patients with chronic renal insufficiency","volume":"63","author":"Cadroy","year":"1991","journal-title":"Thromb Res"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1159\/000186641","article-title":"Pharmacokinetics of a low molecular weight heparin (fraxiparine) in various stages of chronic renal failure","volume":"59","author":"Goudable","year":"1991","journal-title":"Nephron"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"pt 1","key":"R14-20250804","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0022-3476(80)80678-0","article-title":"Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria","volume":"96","author":"Lau","year":"1980","journal-title":"J Pediatr"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7326\/0003-4819-107-1-42","article-title":"Protein S deficiency occurs in the nephrotic syndrome","volume":"107","author":"Vigano-D\u2019Angelo","year":"1987","journal-title":"Ann Intern Med"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1681\/ASN.2014111097","article-title":"Disease severity correlates with thrombotic capacity in experimental nephrotic syndrome","volume":"26","author":"Kerlin","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-62703-339-8_19","article-title":"Anti-factor Xa (anti-Xa) assay","volume":"992","author":"Newall","year":"2013","journal-title":"Methods Mol Biol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/ndt\/gfg396","article-title":"Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysis","volume":"18","author":"Guillet","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.thromres.2014.03.036","article-title":"Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients","volume":"133","author":"Pon","year":"2014","journal-title":"Thromb Res"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2004.10.004","article-title":"Dosage of enoxaparin among obese and renal impairment patients","volume":"116","author":"Bazinet","year":"2005","journal-title":"Thromb Res"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0091270006289975","article-title":"The pharmacokinetics of enoxaparin do not correlate with its pharmacodynamic effect in patients receiving dialysis therapies","volume":"46","author":"Brophy","year":"2006","journal-title":"J Clin Pharmacol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:09:45Z","timestamp":1754338185000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002045","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2020,12,23]]},"assertion":[{"value":"2020-06-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}